Tag: Medical Research
Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a COVID-19 Vaccine Under Fast Track CARES Act
eNewsChannels NEWS: -- Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the Nanovaccine Institute at Iowa State University to study a nasal SARS-CoV-2 vaccine. Zeteo will provide nasal delivery device technology and unit dose packaging utilizing its ZEOx2 Delivery Platform.
2020 International Clostridioides difficile (C. diff.) Virtual Conference and Health EXPO Nov. 14
eNewsChannels NEWS: -- C Diff Foundation announced today that the 8th Annual International C. diff. Virtual-Online Conference and Health EXPO will be a 5-1/2 hour online program with over fourteen international topic-experts dedicated in disciplines of healthcare, pharma, biotech, academia, and Government agencies.
At ACG 2020 Progenabiome Shares New Data on Fecal Transplant and Sars-Cov-2
eNewsChannels NEWS: -- The American College of Gastroenterology (ACG) named Progenabiome "Outstanding Poster Presenter" for its poster: "Successful Bacterial Engraftment Identified by Next Generation Sequencing Following Fecal Microbiota Transplantation for Clostridioides difficile Infection," which will be presented virtually at the ACG Annual Scientific Meeting this week.
Microbiome Expert Dr. Sabine Hazan of ProgenaBiome Shares Evidence of Alzheimer’s Improvement Post-FMT
eNewsChannels NEWS: -- Dr. Sabine Hazan, founder of ProgenaBiome, a genetic sequencing lab in California, achieved rapid improvement in Alzheimer's disease (AD) symptoms in an 82-year-old male patient following fecal microbiota transplantation (FMT).
Leading Infectious Disease Research Scientist Michael Mansour, MD, PhD To Serve as Medical Advisor for NED Biosystems
eNewsChannels NEWS: -- NED Biosystems, an innovative clinical-stage biotech company developing therapies for cancer and the novel coronavirus, is pleased to announce that Michael Mansour, MD, PhD, will serve as the Company's Medical Advisor of Infectious Disease.
Cancer Research Experts Nabeel El-Bardeesy and Razelle Kurzrock Join NED Biosystems’ Scientific Advisory Board
eNewsChannels NEWS: -- NED Biosystems, an innovative clinical-stage biotech company developing oral therapies for cancer and novel coronavirus, is pleased to announce that Nabeel El-Bardeesy, PhD and Razelle Kurzrock, MD have joined the Company's Scientific Advisory Board.
Zeblok Computational Inc. Announces Partnership with Laufer Center and CEWIT for Drug Discovery
eNewsChannels NEWS: -- Zeblok Computational is contributing to the efforts of two groups of researchers at The Laufer Center for Physical and Quantitative Biology, for COVID-19 drug discovery by providing Zeblok's secure, scalable Supercomputing-as-a-Service platform, employing 128 GPUs from the CEWIT SMART GPU Cluster.
ROKiT Pharma’s Preclinical Studies Showing Promise for Naturally Derived Cancer Drug, ROK-001 – Moving Towards Phase 1b/2 Clinical Trial
eNewsChannels NEWS: -- ROKiT Pharma, Inc., a public-benefit corporation dedicated to putting patients first, announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural ingredients.
Dr. Daniel Helman: Treating Schizophrenia with Individualized Care
eNewsChannels NEWS: -- Schizophrenia may find a cure in individualized treatment. So says a new article in the science journal Holistic Nursing Practice. According to Dr. Daniel Helman, a researcher on the small island of Yap in Micronesia, long-term recovery is often possible, but appropriate studies are not being done.
Generous Bequests Help Strengthen the Susan G. Komen Dallas County Mission
eNewsChannels NEWS: -- Susan G. Komen Dallas County (Komen Dallas County) today said it has received bequests from the Estate of Edith Beutell and the Estate of Dr. Glenn Dodwell, which combined total more than $199,000. The gifts will further the organization's ability to assess the state of breast health in Dallas County and create plans of action to reduce breast cancer mortality disparities in the community.
